ETX — E-Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- £54.93m
- £23.53m
- £0.48m
Annual cashflow statement for E-Therapeutics, fiscal year end - January 31st, GBP millions except per share, conversion factor applied.
R2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.68 | -8.07 | -8.27 | -11.2 | -14.9 |
| Depreciation | |||||
| Non-Cash Items | -0.397 | -1.04 | -1.82 | -2.57 | -3.74 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.612 | 1.1 | 1.62 | 2.3 | 1.37 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.36 | -7.8 | -8.01 | -10.9 | -16.6 |
| Capital Expenditures | -0.071 | -0.963 | -0.21 | -0.481 | -0.94 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -5 | -8.98 | 15.5 | 0.713 | -11.2 |
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.07 | -9.94 | 15.3 | 0.232 | -12.1 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 12.6 | 22.3 | 13 | -0.359 | 28.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.17 | 4.59 | 20.3 | -11 | -0.146 |